A49869
Applied Biosystems™ TaqPath™ COVID-19 High Throughput Combo Kit
Manufacturer: Applied Biosystems™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | A49869-Each-of-1 | In Stock | ₹ 2,74,81,872.00 |
A49869 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 2,74,81,872.00
GST (18%): ₹ 49,46,736.96
Total Price: ₹ 3,24,28,608.96
Content And Storage
• TaqPath COVID-19 Module 2 Assay Kit, 6 x 2 mL per kit, 3 kits included, store at –10 to –30°C• TaqPath COVID-19 Module 1 MS2 Phage Control, 6 x 15 mL per kit, 3 kits included, store at –10 to –30°C• TaqPath COVID-19 Dilution Buffer, 3 x 2 mL per kit, 3 kits included, store at –10 to –30°C• TaqPath COVID-19 Control, 3 x 2 μL per kit, 3 kits included, store at ≤ –70°C• Product Insert
For Use With (Application)
COVID-19 Diagnostic Testing
Quantity
20,000 Reactions
Species
Human
Detection Method
Primer-Probe Detection
Product Line
TaqPath™
Shipping Condition
Wet ice
Target Organism Class
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Related Products
Description
- The TaqPath COVID-19 High Throughput Combo Kit consists of assays and controls for 20,000 real-time RT-PCR tests for the detection of SARS-COV-2 RNA in preserved saliva, nasal, and nasopharyngeal samples
- Clinical laboratories can run 100 to 8,000 tests in 24 hours using the Amplitude Solution , and the assay kit enables efficient ordering to address high-throughput testing needs
- Features of the TaqPath COVID-19 high-throughput kit include: • Available with 20,000 reactions per kit for preserved saliva, nasal, and nasopharyngeal samples to help maximize specimen throughput • Targeted specificity to 100% of currently available complete genomes for SARS-CoV-2 • Targets spike (S) protein and nucleocapsid (N) protein regions having higher specificity and exhibiting lower risk for mutation This combo kit contains the TaqPath COVID-19 Module 1 MS2 Phage Control, TaqPath COVID-19 Module 2 Assay Kit, TaqPath COVID-19 Control, and TaqPath COVID-19 Control Dilution Buffer
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C
- §263a, that meet requirements to perform high complexity tests
- Access the Instructions for Use approved for your country › Results are for the identification of SARS-CoV-2 RNA
- The SARS-CoV-2 RNA is generally detectable in preserved saliva, nasopharyngeal, and nasal swab specimens during the acute phase of infection
- (See product label for Intended Use Statement and product information)
- The TaqPath COVID-19 Combo Kit is ordered as a single, high-throughput (20,000 reactions) kit and is intended to use with the Amplitude Solution
- This package is to be used in conjunction with the Amplitude High‐Throughput Consumable Package 1 Reagent kit (Cat
- No
- A49598)
- Amplitude High‐Throughput Consumable Package 2 Assay Kit is only for use under the US Food and Drug Administration’s Emergency Use Authorization
- The ordering of the Amplitude Solution reagents and consumables is managed by your Sales Representative in accordance with your laboratory Supply Agreement.